Skip to content
healthcare.dev

Glipizide

NDC 51655-337, Glipizide, tablet, film coated, extended release, from Northwind Health Company, LLC.

Product NDC
51655-337
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204720
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-337 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLIPIZIDE5 mg/1

Pharmacologic classes

Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
51655-337-265165503372690 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-337-26)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ab2f4ea6-46e8-268a-e053-2995a90a3977

Use it

Look up 51655-337 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-337 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-337. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.